The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Oxidative Stress in the Progression of Alzheimer Disease in the Frontal Cortex
Open accessAbstract
We investigated oxidative stress in human postmortem frontal cortexfrom individuals characterized as mild cognitive impairment (n= 8), mild/moderate Alzheimer disease (n = 4), and late-stage Alzheimer disease (n = 9). Samples from subjects with no cognitive impairment (n = 10) that were age- and postmortem interval-matched with these cases were used as controls. The short postmortem intervalbrain samples were processed for postmitochondrial supernatant, nonsynaptic mitochondria, and synaptosome fractions. Samples were analyzed for several antioxidants (glutathione, glutathione peroxidase, glutathione reductase, glutathione-S-transferase, glucose-6-phosphate dehydrogenase, superoxide dismutase, catalase) and the oxidative marker, thiobarbituric acid reactive substances. The tissue was also analyzed for possible changes in protein damage using neurochemical markers for protein carbonyls, 3-nitrotyrosine, 4-hydroxynonenal, andacrolein. All 3 neuropil fractions (postmitochondrial supernatant, mitochondrial, and synaptosomal) demonstrated significant disease-dependent increases in oxidative markers. The highest changes were observed in the synaptosomal fraction. Both mitochondrial and synaptosomal fractions had significant declines in antioxidants (glutathione, glutathione peroxidase, glutathione-S-transferase, and superoxide dismutase). Levels of oxidative markers significantly correlated with Mini-Mental Status Examination scores. Oxidative stress was more localized to the synapses, with levels increasing in a disease-dependent fashion. These correlations implicate an involvement of oxidative stress in Alzheimer disease-related synaptic loss.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, TNT formation is often associated with oxidative stress, another key feature of AD [120,121,122].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [121]
Experimental — accuracy not yet measuredIn the citing paper
“3-nitrotyrosine and protein carbonyls, these last produced mainly by the action of free radicals on the peptide chain or by oxidation of amino acids, are used as biomarkers of oxidative damage in the brain of AD and MCI [18,24,31,32,33].”
From Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery (2021) · cites this paper as [31]
In the citing paper
“In response to OS in the brain, a number of protective mechanisms are up regulated to maintain the oxidative balance, in particular compensatory induction of antioxidant enzymes such as superoxide dismutase, glutathione reductase, catalase have been found in vulnerable neurons in AD [31].”
From Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery (2021) · cites this paper as [31]
In the citing paper
“Reduction of antioxidants such as glutathione, glutathione peroxidase, glutathione-S-transferase, and superoxide dismutase are demonstrated post-mortem in the mitochondrial and synaptosomal fractions in the frontal cortex of MCI and AD patients [31].”
From Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery (2021) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., & Freeman, B. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1620 · Cited by 7,029
Current concepts in mild cognitive impairment
Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., Ritchie, K., Rossor, M., Thal, L., & Winblad, B. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.1985 · Cited by 4,781
Reactive Oxygen Species and the Central Nervous System
Halliwell, B. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb10990.x · Cited by 2,947
Oxidative Damage Is the Earliest Event in Alzheimer Disease
Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.8.759 · Cited by 1,885
Mild Cognitive Impairment Represents Early-Stage Alzheimer Disease
Morris, J. C., Storandt, M., Miller, J. P., McKeel, D. W., Price, J. L., Rubin, E. H., & Berg, L. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.397 · Cited by 1,871
Halliwell, B. (2001) · Drugs & Aging · doi:10.2165/00002512-200118090-00004 · Cited by 1,502
Synaptic Activity Regulates Interstitial Fluid Amyloid-β Levels In Vivo
Cirrito, J. R., Yamada, K. A., Finn, M. B., Sloviter, R. S., Bales, K. R., May, P. C., Schoepp, D. D., Paul, S. M., Mennerick, S., & Holtzman, D. M. (2005) · Neuron · doi:10.1016/j.neuron.2005.10.028 · Cited by 1,265
Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease
Smith, M. A., Richey Harris, P. L., Sayre, L. M., Beckman, J. S., & Perry, G. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02653.1997 · Cited by 1,239
Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior
Selkoe, D. J. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.02.016 · Cited by 1,038
Cited by
Sorted by citations
Items 401–500 of 623
Tang, K. S. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118287 · Cited by 12
The search for anti‐oxytotic/ferroptotic compounds in the plant world
Soriano‐Castell, D., Liang, Z., Maher, P. A., & Currais, A. J. M. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15517 · Cited by 12
Nikolova, G., Ananiev, J. R., Иванов, В., Petkova-Parlapanska, K., Georgieva, E., & Karamalakova, Y. D. (2022) · Antioxidants · doi:10.3390/antiox11091678 · Cited by 12
Perspectives on Alzheimer’s Disease Treatment Based on Counteracting Oxidative Stress
Bilski, R., Dąbkowski, S., Kozieł, I., Kozicki, M., Małachowska, A., Przygocki, M., & Tyska, O. (2025) · Biomolecules · doi:10.3390/biom15091345 · Cited by 13
Volonté, C., Hu, G., Shaw, C. A., Claudio, V. J., dos Santos, J. A., Vaz, S. H., Sebastião, A. M., Balcar, V. J., Mozley, P. D., Verde, F., et al. (2026) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2026.1004136 · Cited by 12
Recent Updates on the Development of Therapeutics for the Targeted Treatment of Alzheimer’s Disease
Rajput, S., Malviya, R., Bahadur, S., & Puri, D. (2023) · Current Pharmaceutical Design · doi:10.2174/0113816128274618231105173031 · Cited by 12
Targeting Metals in Alzheimer’s Disease: An Update
Du, B., Chen, K., Wang, W., & Lei, P. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240140 · Cited by 13
Dastan, M., Rajaei, Z., Sharifi, M., & Salehi, H. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04638-y · Cited by 15
End products of lipid peroxidation in erythrocyte membranes in Alzheimer's disease
Skoumalová, A., Mádlová, P., & Topinková, E. (2011) · Cell Biochemistry and Function · doi:10.1002/cbf.1836 · Cited by 11
Gałecki, P., Talarowska, M. E., Bobińska, K., Kowalczyk, E., Gałecka, E., & Lewiñski, A. (2013) · PubMed · Cited by 11
de Mendonca, E., Alcalá, E. S., & Fernández‐Mestre, M. (2016) · Neurología (English Edition) · doi:10.1016/j.nrleng.2014.10.007 · Cited by 11
Das, M., Balan, D. J., & Devi, K. P. (2021) · NeuroToxicology · doi:10.1016/j.neuro.2021.08.003 · Cited by 11
Yang, H., Jia, H.-W., Deng, M., Zhang, K., Liu, Y., Liu, Y., Cheng, M., & Xiao, W. (2023) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2023.2192439 · Cited by 11
Jin, B., Cheng, X., Fei, G., Sang, S., & Zhong, C. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1169620 · Cited by 11
Role of S-adenosylmethionine in the Modulation of Oxidative Stress- Related Neurodegeneration
Cavallaro, R. A., Fuso, A., D’Erme, M., Miraglia, N., Martire, S., Scarpa, S., & Mosca, L. (2016) · International Journal of Clinical Nutrition & Dietetics · doi:10.15344/2456-8171/2016/109 · Cited by 11
Chen, C., Ding, Q., Shen, B., Yu, T., Wang, H., Xu, Y., Guo, H., Hu, K., Xie, L. Y., Wang, G., et al. (2019) · Drug Metabolism and Disposition · doi:10.1124/dmd.119.089458 · Cited by 11
Olayinka, J. N., Eduviere, A. T., Adeoluwa, O. A., Akinluyi, E. T., Obisesan, A. O., Akawa, O. B., & Adebanjo, A. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00861-x · Cited by 12
Redox Regulation of Cysteine-Dependent Enzymes in Neurodegeneration
Guttmann, R. P., & Powell, T. J. (2012) · International Journal of Cell Biology · doi:10.1155/2012/703164 · Cited by 14
Piccirillo, S., Preziuso, A., Cerqueni, G., Serfilippi, T., Terenzi, V., Vinciguerra, A., Amoroso, S., Lariccia, V., & Magi, S. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115869 · Cited by 10
Culibrk, R. A., Ebbert, K. A., Yeisley, D. J., Chen, R., Qureshi, F. A., Hahn, J., & Hahn, M. S. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-230600 · Cited by 10
Effect of Oxidative Stress on Homer Scaffolding Proteins
Nepliouev, I., Zhang, Z.-S., & Stiber, J. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026128 · Cited by 10
Role of Oxygen Radicals in Alzheimer’s Disease: Focus on Tau Protein
Atlante, A., Valenti, D., Latina, V., & Amadoro, G. (2021) · Oxygen · doi:10.3390/oxygen1020010 · Cited by 11
Ben‐Azu, B., Oghorodi, A. M., Oritsemuelebi, B., & Chidebe, E. O. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.112517 · Cited by 9
Therapeutic agents for Alzheimer’s disease: a critical appraisal
Weinstock, M. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1484615 · Cited by 9
Research Progress on Phytochemicals from Mulberry with Neuroprotective Effects: A Review
Chen, J., Gou, Z., Huang, Y., Yu, Q., Kim, A. N., Shi, W., & Zhou, Y. (2025) · Pharmaceuticals · doi:10.3390/ph18050695 · Cited by 9
Beretti, F., Malenchini, M., Gatti, M., & Maraldi, T. (2025) · Biomedicines · doi:10.3390/biomedicines14010059 · Cited by 12
Silwal, A., House, A., Sandoval, K. E., Vijeth, S., Umbaugh, D. S., Crider, A. M., Mobayen, S., Neumann, W. L., & WITT, K. A. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03482-z · Cited by 8
Cheng, Q., Wang, J., Wu, A., Zhang, R., Li, L., & Yue, Y. (2013) · Neurological Sciences · doi:10.1007/s10072-013-1314-z · Cited by 9
Shafin, N., Zakaria, R., Hussain, N. H. N., & Othman, Z. (2012) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31827758c6 · Cited by 10
Žižková, M. (., Suchá, R., Tylečková, J., Jarkovská, K., Mairychová, K. (., Kotrčová, E., Maršala, M., Gadher, S. J., & Kovářová, H. (2014) · Expert Review of Proteomics · doi:10.1586/14789450.2015.977381 · Cited by 9
Unregulated Lipid Peroxidation in Neurological Dysfunction
Shichiri, M., Yoshida, Y., & Niki, E. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-410527-0.00004-1 · Cited by 10
Ingle, B., Shrestha, B., Jesus, M. C. D., Conrad-Webb, H., Anderson, M. E., & Cundari, T. R. (2018) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2018.11.008 · Cited by 9
Platelets mirror changes in the frontal lobe antioxidant system in Alzheimer's disease
Ercan, H., Reumiller, C. M., Mühlberger, J., Hsu, F., Schmidt, G. J., Umlauf, E., Miller, I., Rappold, E., Attems, J., Oehler, R., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70117 · Cited by 9
High serum 8-hydroxy-2′-deoxyguanosine levels predict DNA damage and aging in professional divers
Güneş, A. E., Yılmaz, Ö., Erbaş, C., Daglı, S. N., & Çelık, H. (2021) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.20210748 · Cited by 8
Su, Y.-H., Chang, C., Hsu, J.-Y., Li, S., Sung, P., Wang, R.-H., Wu, C., & Liao, P. (2023) · Molecules · doi:10.3390/molecules28052166 · Cited by 8
Melatonin Supplementation in Alzheimer’s disease: The Potential Role in Neurogenesis
Ebrahimi, R., Faramarzi, A., Salarvandian, S., Zarei, R., Heidari, M., Salehian, F., & Esmaeilpour, K. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05095-x · Cited by 8
Jovanović, M., Jelenković, A., Stevanović, I. D., Bokonjić, D., Čolić, M. J., Petronijević, N., & Stanimirovic, D. B. (2014) · Europe PMC (PubMed Central) · Cited by 8
Neuroprotective effects of Flaveria bidentis and Lippia salsa extracts on SH-SY5Y cells
Cavallaro, V., Baier, C. J., Murray, M. G., Estévez‐Braun, A., & Murray, A. P. (2018) · South African Journal of Botany · doi:10.1016/j.sajb.2018.10.006 · Cited by 8
Neurodegenerative Diseases: Potential Effect of Glutathione
Moustapha, A. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.92240 · Cited by 8
Antioxidants Mitigate Oxidative Stress: A General Overview
Umber, J., Qasim, M., Ashraf, S., Ashfaq, U. A., Mahmood-ur-Rahman, Iram, A., Bhatti, R., Tariq, M., & Masoud, M. S. (2023) · Food bioactive ingredients · doi:10.1007/978-3-031-41188-5_7 · Cited by 8
Oophorectomy hinders antioxidant adaptation promoted by swimming in Wistar rats
Macedo, U. B. D. O., Martins, R. R., Neto, F. P. F., Oliveira, Y. M. D. C., Medeiros, A. D. C., Brandão‐Neto, J., de Rezende, A. A., & Almeida, M. D. G. (2013) · Applied Physiology Nutrition and Metabolism · doi:10.1139/apnm-2012-0121 · Cited by 8
Oboh, G., Olatunde, D., Ademosun, A. O., & Ogunsuyi, O. B. (2021) · Journal of Food Biochemistry · doi:10.1111/jfbc.13616 · Cited by 8
Scheffler, F., Ipser, J., Pancholi, D., Murphy, A., Cao, Z., Ottino‐González, J., ENIGMA Addiction Working Group, Thompson, P. M., SHOPTAW, S. J., Conrod, P., et al. (2024) · Addiction · doi:10.1111/add.16621 · Cited by 7
Detcheverry, F. E., Senthil, S., Motue, W. L. K., Hosein, C., Arnaoutelis, R., Araújo, D., Fetco, D., Assemlal, H.-E., Antel, S. B., Arnold, D. L., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70456 · Cited by 9
Ansari, M. A., Al‐Jarallah, A., Rao, M. S. R., Babiker, A., & Bensalamah, K. (2024) · Brain Research · doi:10.1016/j.brainres.2024.148890 · Cited by 7
Self-citationSharallah, O. A., Poddar, N. K., & Alwadan, O. A. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102394 · Cited by 7
Naz, F., Seraj, F., Taha, M., Özil, M., Salar, U., Baltaş, N., Ul‐Haq, Z., Tariq, S., & Khan, K. M. (2024) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2024.140317 · Cited by 7
Electrochemical biosensors for early detection of Alzheimer’s disease
Jakhonkulovna, S. M., Kamolovna, G. B., Zokirov, M., Tajimuratovna, B. U., Yumashev, A., SHICHIYAKH, R. A., Safarova, N. I., Nusratovna, A. N., Esanmuradova, N., Karimbaevna, T. M., et al. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120278 · Cited by 11
Long, J., Aksenov, V., Rollo, C. D., & Liu, J. (2012) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2012.04.001 · Cited by 7
Chaudhary, S., & Parvez, S. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.07.156 · Cited by 7
Uysal, Ş., Parlar, S., Tarikogullari, A. H., Köse, F. A., Alptüzün, V., & Soyer, Z. (2018) · Archiv der Pharmazie · doi:10.1002/ardp.201700273 · Cited by 7
Rahman, M. A., Hossain, S., Abdullah, N., & Aminudin, N. (2019) · AIMS neuroscience · doi:10.3934/neuroscience.2019.4.299 · Cited by 7
Amyloid Beta (Aβ) and Oxidative Stress: Progression of Alzheimer’s Disease
Haque, R. (2018) · Advances in Biotechnology & Microbiology · doi:10.19080/aibm.2018.11.555802 · Cited by 7
Utilization of Complementary and Alternative Therapies in Youth with Developmental Disabilities
Tenenbaum, R. B., Agarwal, R., Cooke, M. S., Agrawal, M. M., Maddux, M., & Burke, S. L. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/3630509 · Cited by 7
Li, X., Zhang, Y., Ding, X., Jin, Y., Wei, C., & Xu, J. (2023) · Metabolites · doi:10.3390/metabo13111150 · Cited by 6
Vo, T. T. T., Tsai, M.-H., Cheng, C.-Y., Wang, Y.-L., Lee, W.-J., & Lee, I. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117362 · Cited by 7
Brain Glutathione Levels Associate With Cognitive Performance in Older Adults
Lee, P., Erickson, K. I., Kang, C., Burns, J. M., Hillman, C. H., Kramer, A. F., Grove, G., Vidoni, E. D., Huang, H., McAuley, E., et al. (2026) · Journal of Neurochemistry · doi:10.1111/jnc.70343 · Cited by 6
Ferroptosis in neurological diseases: moving towards therapeutic intervention
Tuo, Q., Bush, A. I., & Lei, P. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03445-2 · Cited by 11
Qian, J., Li, Y., Wang, Y., Ye, Q., & Luo, H.-B. (2023) · Redox Report · doi:10.1080/13510002.2023.2259246 · Cited by 6
Senolytics prevent age-associated changes in female mice brain
Faria, O. W., Soares, M. S. P., de Mello, J. E., Alvez, F. L., Luduvico, K. P., Garcia, D. N., Schneider, A., Masternak, M. M., Spanevello, R. M., & Stefanello, F. M. (2024) · Neuroscience Letters · doi:10.1016/j.neulet.2024.137730 · Cited by 6
Yang, E. J. (2024) · Applied Sciences · doi:10.3390/app14135386 · Cited by 6
Guan, L., Hao, Y., Chen, L., Wei, M., Jiang, Q., Liu, W., Zhang, Y., Zhang, J., Feng, F., & Qu, W. (2016) · RSC Advances · doi:10.1039/c5ra21313d · Cited by 6
Naturally Occurring Antioxidants
Ronzio, R. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-43044-9.00097-2 · Cited by 6
2D and 3D Models of Alzheimer’s Disease: Investigating Neuron-like Cells in Oxidative Environments
Salles, G. N., Giraldi, L. A., da Silva, N. S., Porcionatto, M. A., & Soares, C. P. (2025) · ACS Omega · doi:10.1021/acsomega.5c03306 · Cited by 5
The Role of Inflammation in Alzheimer’s Disease
Müller, N., Krause, D., Schwarz, M., Weidinger, E., & Reinisch, V. M. (2015) · Current topics in neurotoxicity · doi:10.1007/978-3-319-13602-8_15 · Cited by 5
Antioxidant Plant Polyphenols and Cognitive Disorders
Nowak, D. (2014) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-1-4939-0440-2_26 · Cited by 5
Gursahani, M., Gawali, N. B., Pai, S. A., Mestry, S. N., & Juvekar, A. R. (2021) · Journal of Pharmaceutical Research International · doi:10.9734/jpri/2021/v33i331164 · Cited by 5
Cinnamoyl-memantine hybrids: Synthesis, X-ray crystallography and biological activities
Chochkova, M. G., Jiang, H., Kyoseva, R., Stoykova, B., Tsvetanova, E. R., Alexandrova, A., Liu, R., Li, Z., Mitrev, Y., Sbirkova-Dimitrova, H. I., et al. (2021) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2021.130147 · Cited by 6
Alzheimer's Disease and the Immune System
Cao, C. (2015) · SOJ Neurology · doi:10.15226/2374-6858/2/1/00112 · Cited by 5
Targeting fibrin in neurodegeneration
Martinꝉ, R. (2018) · Nature Immunology · doi:10.1038/s41590-018-0241-9 · Cited by 5
Bawa, K. K., Ba, J., Kiss, A., Wang, R., Feng, V., Swardfager, W., Andreazza, A. C., Gallagher, D., Marotta, G., Herrmann, N., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220274 · Cited by 4
Mesa-Herrera, F., Marín, R., Torrealba, E., & Díaz, M. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215437 · Cited by 4
Coria-Lucero, C. D., Castro, A., Ledezma, C., Leporatti, J., Ramírez, D. C., Ghersi, M., Delgado, S. M., Anzulovich, A. C., & Navigatore-Fonzo, L. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148242 · Cited by 4
Zhu, J., Xu, Z., Gao, P., & Liu, X. (2024) · South African Journal of Botany · doi:10.1016/j.sajb.2024.08.005 · Cited by 4
Beneficial and Detrimental Effects of Uric Acid on Alzheimer’s Disease
Товчига, О. В., & Inkielewicz‐Stępniak, I. (2025) · Current Neuropharmacology · doi:10.2174/011570159x349365250128072146 · Cited by 5
Mitochondrial Quality Control: Decommissioning Power Plants in Neurodegenerative Diseases
Mukherjee, R., & Chakrabarti, O. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/180759 · Cited by 4
Interplay Between Hippocampal Glutathione Depletion and pH Increment in Alzheimer’s Disease
Mandal, P. K., Dwivedi, D., Shukla, D., Samkaria, A., Roy, R. G., Arora, Y., & Jindal, K. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215729 · Cited by 4
Dastan, M., Rajaei, Z., Sharifi, M., & Salehi, H. (2024) · Research Square · doi:10.21203/rs.3.rs-3862785/v1 · Cited by 4
Liu, S., He, Y., Chen, H., Zhao, W., Xu, H., Bai, T., & Feng, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-02097-6 · Cited by 7
Ferroptosis-related stress during aging and its relevance to disease
Maher, P. A., Soriano‐Castell, D., Dar, N. J., Soriano, S., & Currais, A. J. M. (2025) · GeroScience · doi:10.1007/s11357-025-01929-7 · Cited by 6
Nuclear factor erythroid 2-related factor 2 in Alzheimer's disease
Murphy, K. E., & Park, J. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815868-5.00015-3 · Cited by 3
Wu, H., Wang, L., Qian, X., Wang, W., Si, Y., Sun, R., & Akkaya, E. U. (2024) · Smart Molecules · doi:10.1002/smo.20230019 · Cited by 3
Alotaibi, B. S., Saleem, U., Farrukh, M., Waseem, S., Chauhdary, Z., Alsharif, I., Al-Qahtani, W. S., Alanzi, A. R., BinMowyna, M. N., Shah, M. A., et al. (2024) · Italian Journal of Food Science · doi:10.15586/ijfs.v36i3.2643 · Cited by 3
Azarfarin, M., Moradikor, N., Salatin, S., Sarailoo, M., & Dadkhah, M. (2025) · Progress in brain research · doi:10.1016/bs.pbr.2025.01.011 · Cited by 3
Ahsan, R., Khan, M. M., Mishra, A., Noor, G., & Ahmad, U. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149650 · Cited by 3
Du, L., Sun, Y., Gan, Y., Wang, L., Li, X., Yan, S., Xiao, X. H., Li, S., & Jin, H. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2499700 · Cited by 3
Chen, J. J., Kang, Y., Gallagher, D., Herrmann, N., Survilla, K., Vieira, D., Mah, E., Graham, S. J., Kiss, A., Black, S. E., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70230 · Cited by 3
Tzekaki, E. E., Katsipis, G., Chatzikostopoulos, A., Koutoupa, A., Lavrentiadou, S. N., Tsolaki, M., & Pantazaki, Α. A. (2025) · Biology · doi:10.3390/biology14050548 · Cited by 4
Discovery of small molecules for the treatment of Alzheimer’s disease
Rao, P. P. N., Pham, A. T., & Shakeri, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818349-6.00011-x · Cited by 3
Adnan, M., Pramaningtyas, M. D., Islamiana, D., & Sudarto, H. A. (2022) · Mutiara Medika: Jurnal Kedokteran dan Kesehatan · doi:10.18196/mmjkk.v22i1.8167 · Cited by 3
The Impact of Uremic Toxins on Alzheimer's Disease
Zheng, Y., Ji, B., Chen, S., Zhou, R., & Ni, R. (2022) · Current Alzheimer Research · doi:10.2174/1567205019666220120113305 · Cited by 3
Khan, A. U., Mohany, M., Khan, H. U., Fozia, F., Khan, S., Kamran, N., Khan, F. U., Al-Rejaie, S. S., Ahmad, I., Zaghloul, N. S. S., et al. (2023) · Open Chemistry · doi:10.1515/chem-2022-0299 · Cited by 3
Datta, D. (2023) · The Journals of Gerontology Series A · doi:10.1093/gerona/glad134 · Cited by 3
Longitudinal Monitoring of Glutathione Stability in Different Microenvironments
Arora, Y., Samkaria, A., Maroon, J. C., & Mandal, P. K. (2024) · Neurochemical Research · doi:10.1007/s11064-024-04265-y · Cited by 3
Murakami, K., Kato, H., Hanaki, M., Monobe, Y., Akagi, K., Kawase, T., Hirose, K., & Irie, K. (2020) · RSC Advances · doi:10.1039/d0ra03429k · Cited by 3
Impact of Oxidative - Nitrosative Stress on Cholinergic Presynaptic Function
Stefanie, A. G., & Jane, R. (2011) · InTech eBooks · doi:10.5772/20198 · Cited by 3
Naturally Occurring Antioxidants
Ronzio, R. A. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4377-2333-5.00108-5 · Cited by 3
Sapitri, M., Kanedi, M., Busman, H., & Sutyarso, S. (2014) · Jurnal Ilmiah Biologi Eksperimen dan Keanekaragaman Hayati (J-BEKH) · doi:10.23960/jbekh.v2i2.117 · Cited by 3
Danna, R., Kondle, S., Amar, O., Mabourakh, M., Chen, G., Fadol, W. B., & Mohieldin, A. M. (2025) · Biology · doi:10.3390/biology14121787 · Cited by 2
Metadata
- Authors
- Ansari, M. A., & Scheff, S. W.
- Affiliations
- University of Kentucky (US)
- Corresponding author
- Scheff, Stephen W.
- ORCID
- Ansari, Mubeen A.
- Venue
- Journal of Neuropathology & Experimental Neurology
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-02
- Volume
- 69
- Issue
- 2
- Pages
- 155-167
- ISSN
- 0022-3069 (ISSN-L)
- 1554-6578
- PMC
- PMC2826839
- OpenAlex
- W2031762170
- Cited by
- 605
- References
- 96
- Citations by year
- 2026: 29 · 2025: 38 · 2024: 44 · 2023: 40 · 2022: 51 · 2021: 56 · 2020: 44 · 2019: 38 · 2018: 30 · 2017: 31 · 2016: 41 · 2015: 29 · 2014: 31 · 2013: 24 · 2012: 31
- FWCI
- 21.61
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Neuropathology & Experimental Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (AG-028383, AG27219, P30AG028383, P01AG014449, R01AG043375, R01AG027219)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Keywords
- oxidative stress, Alzheimer's disease, frontal cortex, synaptosomes, mitochondria, antioxidants, glutathione, superoxide dismutase, lipid peroxidation, protein carbonyls, nitrotyrosine, 4-hydroxynonenal, acrolein, synaptic loss, disease progression, mild cognitive impairment, postmortem brain
- MeSH terms
- Aged, Aged, 80 and over, Aldehydes, Alzheimer Disease, Antioxidants, Female, Frontal Lobe, Humans, Male, Mental Status Schedule, Synapses, Tissue Distribution, Tyrosine, Biomarkers, Thiobarbituric Acid Reactive Substances, Oxidative Stress, Disease Progression, Protein Carbonylation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review